Information for authors

Interested in submitting to this journal? We recommend that you review the About the Journal page, our Editorial policies, as well as the Author Guidelines. Authors are required to register with the journal before submitting. If you are already registered, you can simply log in and begin the five-step process."

Peer (Editorial) Review process

The review process for submissions to Antibody Reports follows a meticulous editorial evaluation. Upon receiving a manuscript, an academic editor with expertise in the field conducts a thorough initial quality check to assess its alignment with the journal's scope, the quality of content, and adherence to editorial policies and ethical standards. Submissions may be returned to authors for changes or clarifications at this stage.

Once a submission is accepted, the editor proceeds to the reviewing phase with the aim of ensuring clarity of the data, scientific rigor, and compliance with our publication guidelines. The Editor-in-Chief, leveraging their expertise and insights from the editorial team, makes the final decision on whether to accept, revise, or reject the submission.

In our review model, the editor assumes the dual role of both reviewer and direct interactor with authors and the Editor-in-Chief. This approach establishes an open review identity and encourages interactive reviewing. It fosters direct reciprocal discussions between reviewers and/or between authors and reviewers, enhancing the collaborative nature of the review process.

Typically, the entire reviewing process takes an average of 20 days.

Editors with conflicts of interest related to a submitted manuscript are recused from both the reviewing process and decision-making. In cases where the conflict involves the Editor-in-Chief, he will also be excluded from the reviewing process. In such instances, another editor will temporarily assume the role of Editor-in-Chief to ensure impartiality and maintain the integrity of the review process.

Article Processing Charges

Antibody Reports is hosted by the University of Geneva and is technically supported by the Open Access Publication Service. It is partially supported by public funds and foundations. Our significantly reduced publication fees (CHF 300.-) contribute to covering the expenses associated with publication, including journal production and maintenance. Manuscripts featuring antibodies produced and/or discovered by the Geneva Antibody Facility will be published free of charge. Collaborators affiliated with the University of Geneva are also exempt from these charges.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.